Sagimet Biosciences (SGMT) Current Assets (2022 - 2026)
Sagimet Biosciences (SGMT) posted quarterly Current Assets of $107.7 million for Q1 2026, down 26.26% year-over-year from $146.1 million in Q1 2025, and down 7.46% quarter-over-quarter from $116.4 million in Q4 2025.
Sagimet Biosciences (SGMT) Current Assets (2022 - 2026) Analysis & Trends
Sagimet Biosciences' Current Assets history runs 5 years deep, the most recent figure standing at $107.7 million for Q1 2026.
- In Q1 2026, Current Assets fell 26.26% year-over-year to $107.7 million; the TTM figure through Mar 2026 stood at $107.7 million (down 26.26% YoY), while the FY2025 annual figure was $116.4 million, down 23.81% from the prior year.
- Current Assets for Q1 2026 stood at $107.7 million, down from $116.4 million in the prior quarter.
- The five-year high for Current Assets was $194.5 million in Q1 2024, with the low at $21.4 million in Q2 2023.
- The 5-year median for Current Assets is $119.5 million (2025), against an average of $118.6 million.
- The sharpest annual moves came in 2024 and 2026: Current Assets soared 680.89% in 2024, then fell 26.26% in 2026.
- Sagimet Biosciences' Current Assets stood at $32.8 million in 2022, then surged by 194.72% to $96.6 million in 2023, then jumped by 58.08% to $152.8 million in 2024, then declined by 23.81% to $116.4 million in 2025, then dropped by 7.46% to $107.7 million in 2026.
- Business Quant data shows SGMT's Current Assets at $107.7 million in Q1 2026, $116.4 million in Q4 2025, and $119.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Sagimet Biosciences | 649.79 Mn | 649.79 Mn | - | 243.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 243.99 Mn |
| Mar 31, 2026 | 107.72 Mn |
| Dec 31, 2025 | 116.40 Mn |
| Sep 30, 2025 | 119.48 Mn |
| Jun 30, 2025 | 127.20 Mn |
| Mar 31, 2025 | 146.07 Mn |
| Dec 31, 2024 | 152.77 Mn |
| Sep 30, 2024 | 157.19 Mn |
| Jun 30, 2024 | 166.75 Mn |
| Mar 31, 2024 | 194.49 Mn |
| Dec 31, 2023 | 96.65 Mn |
| Sep 30, 2023 | 102.82 Mn |
| Jun 30, 2023 | 21.35 Mn |
| Dec 31, 2022 | 32.79 Mn |